Israeli R&D Team Claim To Be Near COVID-19 Vaccine
MIGAL Researchers Had Already Developed An Avian Coronavirus Vaccine
Executive Summary
An Israeli research team has discovered a potential COVID-19 vaccine candidate as a by-product of an avian vaccine they were developing and one of the team’s leaders told Scrip they hope to start producing and testing it by May.
You may also be interested in...
Novo Nordisk Looks To Increase Its Global GLP-1 Lead
Novo Nordisk said it extended its global lead in the GLP-1 space during Q2 and outlined a strategy to dominate the growing market obesity market as its pipeline grows.
'Cutting Edge’ T-knife Gets €66m Series A Financing
T-knife, a developer of T-cell receptors intended for T-cell therapy in solid tumor cancers, says the series A gives its development program three years of financial runway.
Reborn Redx Inks Global Licensing Deal With AstraZeneca
AstraZeneca will take Redx's RXC006 into clinical development, targeting fibrotic diseases, giving valuable credibility to the biotech’s Wnt pathway hypothesis.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports